Giuseppe Campiani
Affiliations: | University of Siena, Italy, Siena, Toscana, Italy |
Area:
MedChemGoogle:
"Giuseppe Campiani"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Papa A, Pasquini S, Galvani F, et al. (2022) Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions. European Journal of Medicinal Chemistry. 246: 114952 |
Guidi A, Prasanth Saraswati A, Relitti N, et al. (2020) (+)-(R)- and (-)-(S)-Perhexiline maleate: Enantioselective synthesis and functional studies on Schistosoma mansoni larval and adult stages. Bioorganic Chemistry. 102: 104067 |
Frydenvang K, Pickering DS, Kshirsagar GU, et al. (2020) The ionotropic glutamate receptor GluA2 in complex with bicyclic pyrimidinedione-based compounds: when small compound modifications have distinct effects on binding interactions. Acs Chemical Neuroscience |
Sirous H, Campiani G, Brogi S, et al. (2020) Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors. Molecules (Basel, Switzerland). 25 |
Relitti N, Saraswati AP, Federico S, et al. (2020) Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials. Current Topics in Medicinal Chemistry. 20: 433-457 |
Battah B, Chemi G, Butini S, et al. (2019) A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles. Molecules (Basel, Switzerland). 24 |
Saccoccia F, Brindisi M, Gimmelli R, et al. (2019) Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents. Acs Infectious Diseases |
Grillo A, Chemi G, Brogi S, et al. (2019) Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems. European Journal of Medicinal Chemistry. 183: 111674 |
Sirous H, Chemi G, Campiani G, et al. (2019) An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction. Computational Biology and Chemistry. 83: 107105 |
Sirous H, Chemi G, Gemma S, et al. (2019) Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using Structure-Based Combinatorial Library Design Approach. Frontiers in Chemistry. 7: 574 |